
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
A. 510(k) Number:
K121455
B. Purpose for Submission:
To obtain a substantial equivalent determination for a premarket notification for the
BacT/ALERT® FN Plus Culture Bottle .
C. Measurand:
Anaerobic and facultative anaerobic microorganisms.
D. Type of Test:
Liquid culture medium for recovery of microorganisms (anaerobic and facultative
anaerobic) from blood and sterile body fluids using a colorimetric sensor and
reflected light to monitor the presence and production of carbon dioxide (CO ) that is
2
dissolved in the culture medium.
E. Applicant:
bioMerieux, Inc.
F. Proprietary and Established Names:
BacT/ALERT® FN Plus Culture Bottle
G. Regulatory Information:
1. Regulation section:
21 CFR 866.2560
2. Classification:
Class I
1

--- Page 2 ---
3. Product code:
MDB
4. Panel:
83 Microbiology
H. Intended Use:
1. Intended use(s):
BacT/ALERT® FN Plus Culture Bottles are used with the BacT/ALERT®
Microbial Detection System in qualitative procedures for recovery and detection
of anaerobic and facultative anaerobic microorganisms from blood and other
normally sterile body fluids.
2. Indication(s) for use:
BacT/ALERT® FN Plus Culture Bottles are used with the BacT/ALERT®
Microbial Detection System in qualitative procedures for recovery and detection
of anaerobic and facultative anaerobic microorganisms from blood and other
normally sterile body fluids.
3. Special conditions for use statement(s):
Prescription Use Only
4. Special instrument requirements:
BacT/ALERT® Microbial Detection System
I. Device Description:
The BacT/ALERT® FN Plus Culture Bottle is a change from the cleared
BacT/ALERT® FN Culture Bottle. The BacT/ALERT® FN Culture Bottles are used
with the BacT/ALERT® Microbial Detection System in qualitative procedures for the
recovery and detection of microorganisms from blood.
BacT/ALERT® FN Culture Bottle contains charcoal for it antimicrobial neutralization
properties, in a complex growth medium. The charcoal is eliminated in the
BacT/ALERT® FN Plus Culture Bottle, and is replaced with two types of adsorbent
polymeric beads in the complex growth medium.
The BacT/ALERT® Microbial Detection System provides both a microbial detection
2

--- Page 3 ---
system and a culture medium bottle with suitable nutritional and environmental
conditions for microorganism commonly encountered in blood or other normally
sterile body fluid samples (except urine) taken from a patient suspected of having
bacteremia/fungemia. An inoculated bottle is placed into the instrument where it is
incubated and continuously monitored for the presence of microorganisms that will
grow in the BacT/ALERT® Culture Bottles.
The BacT/ALERT® Microbial Detection System utilizes a colorimetric sensor and
reflected light to monitor the presence and production of carbon dioxide (CO ) that is
2
dissolved in the in the culture medium. If microorganisms are present in the test
sample, carbon dioxide is produced as the microorganisms metabolize the substrates
in the culture medium. When growth of the microorganisms produces CO , the color
2
of the gas-permeable sensor installed in the bottom of each culture bottle changes
from blue-green to yellow. The lighter color results in an increase of reflectance units
monitored by the system. Bottle reflectance is monitored and recorded by the
instrument every 10 minutes.
J. Substantial Equivalence Information:
1. Predicate device name(s):
Bact/ALERT® FN Culture Bottle
2. Predicate 510(k) number(s):
K020815
3. Comparison with predicate:
Similarities
Item Device Predicate
Intended Use BacT/ALERT® FN Plus Culture BacT/ALERT® FN Culture
Bottles are used with the Bottles are used with the
BacT/ALERT® Microbial BacT/ALERT® Microbial
Detection System in qualitative Detection System in qualitative
procedures for recovery and procedures for enhanced
detection of anaerobic and recovery and detection of
facultative anaerobic anaerobic microorganisms from
microorganisms from blood and blood and other normally sterile
other normally sterile body fluids. body fluids.
Technology Reflectance Same
Sensor Colorimetric/CO Same
2
detection
Median Fill Volume 40ml Same
Headspace Gases Comprised of CO and N Same
2 2
3

[Table 1 on page 3]
Similarities								
	Item			Device			Predicate	
Intended Use			BacT/ALERT® FN Plus Culture
Bottles are used with the
BacT/ALERT® Microbial
Detection System in qualitative
procedures for recovery and
detection of anaerobic and
facultative anaerobic
microorganisms from blood and
other normally sterile body fluids.			BacT/ALERT® FN Culture
Bottles are used with the
BacT/ALERT® Microbial
Detection System in qualitative
procedures for enhanced
recovery and detection of
anaerobic microorganisms from
blood and other normally sterile
body fluids.		
Technology			Reflectance			Same		
Sensor			Colorimetric/CO
2
detection			Same		
Median Fill Volume			40ml			Same		
Headspace Gases			Comprised of CO and N
2 2			Same		

--- Page 4 ---
Differences
Item Device Predicate
Software Knowledge base Knowledge base
specifications updated to specifications in place to
enable system to enable system to
recognize the BTA FN recognize the BTA FN
Plus bottle type via bottle type via barcodes
barcodes printed on the printed on the bottles.
bottles.
Antibiotic Neutralization Via resin/adsorbent Via charcoal slurry
polymeric beads
Media Ingredients Peptones 1.48% w/v Soybean Casein Digest
2.0 % w/v
SPS 0.083 % w/v SPS 0.044% w/v
Menadione Menadione
0.00005% w/v 0.0000625% w/v
Hemin 0.001% w/v Hemin 0.000625% w/v
Pyridoxine HCL Pyridoxine HCL
0.0008% w/v 0.001% w/v
Sample Volume Range Up to 10 mL Up to 4 mL
(Blood)
K. Standard/Guidance Document Referenced (if applicable):
1. CLSI M100-S21, Performance Standards for Antimicrobial Susceptibility
Testing, Twenty-first Informational Supplement, 2011
2. Clinical and Laboratory Standards Institute (CLSI) M22-A3, Quality Control for
Commercially Prepared Microbiology Culture Media, 2004
3. CLSI M47-A, Principles and Procedures for Blood Cultures; Approved
Guidelines, 2007
4. CLSI EP5-A2, Evaluation of Precision Performance of Clinical Chemistry
Devices, Approved Guidelines, 2004
5. CLSI EP 12-A2, User Protocol for Evaluation of Qualitative Test Performance,
Approved Guideline, 2008
L. Test Principle:
If microorganisms are present in the test sample inoculated into the
BacT/ALERT® FN Plus Culture Bottle, CO will be produced when the
2
organisms metabolize the substrates in the culture medium. When growth of
4

[Table 1 on page 4]
Differences								
								
	Item			Device			Predicate	
Software			Knowledge base
specifications updated to
enable system to
recognize the BTA FN
Plus bottle type via
barcodes printed on the
bottles.			Knowledge base
specifications in place to
enable system to
recognize the BTA FN
bottle type via barcodes
printed on the bottles.		
Antibiotic Neutralization			Via resin/adsorbent
polymeric beads			Via charcoal slurry		
Media Ingredients			Peptones 1.48% w/v			Soybean Casein Digest
2.0 % w/v		
			SPS 0.083 % w/v			SPS 0.044% w/v		
			Menadione
0.00005% w/v			Menadione
0.0000625% w/v		
			Hemin 0.001% w/v			Hemin 0.000625% w/v		
			Pyridoxine HCL
0.0008% w/v			Pyridoxine HCL
0.001% w/v		
Sample Volume Range
(Blood)			Up to 10 mL			Up to 4 mL		

--- Page 5 ---
the microorganisms produces CO , the color of the gas-permeable sensor
2
installed in the bottom of each culture bottle changes from blue-green to
yellow. The lighter color results in an increase of reflectance units monitored
by the system. Bottle reflectance is monitored and recorded by the instrument
every 10 minutes. An analysis of the rate and amount of CO increase enables
2
the BacT/ALERT® Microbial Detection System to determine if the bottle is
positive, i.e., that the test sample contains viable microorganisms.
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
Antimicrobial Neutralization Study
An in-house seeded study was conducted to assess the ability of the
BacT/ALERT® FN Plus Culture Bottle to recover and detect microorganisms in
the presence of antimicrobials. Antimicrobials, in clinically relevant
concentrations, were added directly to the BacT/ALERT® FN Plus Culture Bottles
during inoculation with susceptible strains of obligate and facultative anaerobic
microorganisms. The effectiveness of the antimicrobials was confirmed by
parallel testing using a non-neutralizing culture medium as a control.
The study demonstrated that the following antimicrobials/antimicrobial categories
were effectively neutralized such that susceptible strains of the microorganisms
tested grew in the BacT/ALERT® FN Plus Culture Bottle resulting in a positive
bottle signal within five days or less after inoculation: imipenem, meropenem,
oxacillin, gycylcycline, marcrolides, cefoxitin, ceftaroline, aminoglycosides,
fluoroquinolones, lincosamides, ketolides, and glycopeptides. Antimicrobial
neutralization was not achieved for ceftazidime, ceftriaxone, or cefepime.
Less than complete neutralization was demonstrated for the following
antimicrobials: cefotaxime, cefazolin, ampicillin, penicillin, and ertapenem.
The study results are illustrated in Table 1 below.
®
Table 1. Antimicrobial Neutralization BacT/ALERT FN Plus Culture Bottle
Initial
PSL
Antimicrobial MIC (µg/ml)1, testing % of % Recovery
Antimicrobial conc. Organism
Class 2, 3, 4, 5 conc. PSL (n/N)**
(µg/ml)*
(µg/ml)¥
Clostridium 0%
47 b-lactam </= 0.03 - 0.06 9.4 100%
perfringens (0/17)
Enterococcus 100%
Ampicillin 35.3 b-lactam 0.5 - 2 7.1 75%
faecalis (17/17)
100%
47 b-lactam Escherichia coli 2 - 8 9.4 100%
(17/17)
5

[Table 1 on page 5]
®
Table 1. Antimicrobial Neutralization BacT/ALERT FN Plus Culture Bottle							
Antimicrobial	PSL
conc.
(µg/ml)*	Antimicrobial
Class	Organism	MIC (µg/ml)1,
2, 3, 4, 5	Initial
testing
conc.
(µg/ml)¥	% of
PSL	% Recovery
(n/N)**
Ampicillin	47	b-lactam	Clostridium
perfringens	</= 0.03 - 0.06	9.4	100%	0%
(0/17)
	35.3	b-lactam	Enterococcus
faecalis	0.5 - 2	7.1	75%	100%
(17/17)
	47	b-lactam	Escherichia coli	2 - 8	9.4	100%	100%
(17/17)

--- Page 6 ---
®
Table 1. Antimicrobial Neutralization BacT/ALERT FN Plus Culture Bottle
Initial
PSL
Antimicrobial MIC (µg/ml)1, testing % of % Recovery
Antimicrobial conc. Organism
Class 2, 3, 4, 5 conc. PSL (n/N)**
(µg/ml)*
(µg/ml)¥
b-lactam,
5.9%
b-lactamase
47 / 28 Bacteroides fragilis 0.5/0.25 - 2/1 9.4 / 5.6 50% (1/17)
inhibitor
(w/ blood)
Ampicillin + combination
sulbactam b-lactam,
100%
b-lactamase
47 / 28 Escherichia coli 2/1 - 8/4 9.4 / 5.6 50% (17/17)
inhibitor
(w/ blood)
combination
1st generation 100%
47 Escherichia coli 1 - 4 9.4 25%
Cephalosporin (17/17)
Cefazolin
1st generation Staphylococcus 100%
10 0.25 - 1 2.0 5%
Cephalosporin aureus (17/17)
3rd generation 52.9%
2.5 Escherichia coli 0.03 - 0.12 0.5 3%
Cephalosporin (9/17)
3rd generation Staphylococcus 100%
Cefotaxime 25 1 - 4 5.0 25%
Cephalosporin aureus (17/17)
3rd generation Staphylococcus 94.1%
40 1 - 4 8.0 40%
Cephalosporin aureus (16/17)
100%
2nd generation
132 Bacteroides fragilis 4 - 16 26.4 120% (18/18)
Cephalosporin
(w/ blood)
Cefoxitin 2nd generation 100%
132 Escherichia coli 2 - 8 26.4 120%
Cephalosporin (19/19)
2nd generation Staphylococcus 100%
110 1 - 4 22.0 100%
Cephalosporin aureus (17/17)
100%
Escherichia coli 0.03 - 0.12 4.2 100%
(17/17)
5th generation
Ceftaroline 21
Cephalosporin
Staphylococcus 100%
0.12 - 0.5 4.2 100%
aureus (17/17)
Staphylococcus 100%
Clarithromycin 4.8 Macrolide 0.12 - 0.5 0.96 120%
aureus (17/17)
100%
Bacteroides fragilis 0.5 - 2 2.4 120% (17/17)
(w/ blood)
Clindamycin 12 Lincosamide
Staphylococcus 100%
0.06 - 0.25 2.4 120%
aureus (17/17)
Staphylococcus 100%
Daptomycin 119 Lipopeptide 0.12 - 1 23.8 120%
aureus (17/17)
100%
7.7 Carbapenem Bacteroides fragilis 0.06 - 0.25 1.5 5% (17/17)
(w/ blood)
58.2%
Ertapenem 115.5 Carbapenem Bacteroides fragilis 0.06 - 0.25 23.1 75% (10/17)
(w/ blood)
100%
Staphylococcus
7.7 Carbapenem 0.06 - 0.25 1.5 5% (17/17)
aureus
(w/ blood)
6

[Table 1 on page 6]
®
Table 1. Antimicrobial Neutralization BacT/ALERT FN Plus Culture Bottle							
Antimicrobial	PSL
conc.
(µg/ml)*	Antimicrobial
Class	Organism	MIC (µg/ml)1,
2, 3, 4, 5	Initial
testing
conc.
(µg/ml)¥	% of
PSL	% Recovery
(n/N)**
Ampicillin +
sulbactam	47 / 28	b-lactam,
b-lactamase
inhibitor
combination	Bacteroides fragilis	0.5/0.25 - 2/1	9.4 / 5.6	50%	5.9%
(1/17)
(w/ blood)
	47 / 28	b-lactam,
b-lactamase
inhibitor
combination	Escherichia coli	2/1 - 8/4	9.4 / 5.6	50%	100%
(17/17)
(w/ blood)
Cefazolin	47	1st generation
Cephalosporin	Escherichia coli	1 - 4	9.4	25%	100%
(17/17)
	10	1st generation
Cephalosporin	Staphylococcus
aureus	0.25 - 1	2.0	5%	100%
(17/17)
Cefotaxime	2.5	3rd generation
Cephalosporin	Escherichia coli	0.03 - 0.12	0.5	3%	52.9%
(9/17)
	25	3rd generation
Cephalosporin	Staphylococcus
aureus	1 - 4	5.0	25%	100%
(17/17)
	40	3rd generation
Cephalosporin	Staphylococcus
aureus	1 - 4	8.0	40%	94.1%
(16/17)
Cefoxitin	132	2nd generation
Cephalosporin	Bacteroides fragilis	4 - 16	26.4	120%	100%
(18/18)
(w/ blood)
	132	2nd generation
Cephalosporin	Escherichia coli	2 - 8	26.4	120%	100%
(19/19)
	110	2nd generation
Cephalosporin	Staphylococcus
aureus	1 - 4	22.0	100%	100%
(17/17)
Ceftaroline	21	5th generation
Cephalosporin	Escherichia coli	0.03 - 0.12	4.2	100%	100%
(17/17)
			Staphylococcus
aureus	0.12 - 0.5	4.2	100%	100%
(17/17)
Clarithromycin	4.8	Macrolide	Staphylococcus
aureus	0.12 - 0.5	0.96	120%	100%
(17/17)
Clindamycin	12	Lincosamide	Bacteroides fragilis	0.5 - 2	2.4	120%	100%
(17/17)
(w/ blood)
			Staphylococcus
aureus	0.06 - 0.25	2.4	120%	100%
(17/17)
Daptomycin	119	Lipopeptide	Staphylococcus
aureus	0.12 - 1	23.8	120%	100%
(17/17)
Ertapenem	7.7	Carbapenem	Bacteroides fragilis	0.06 - 0.25	1.5	5%	100%
(17/17)
(w/ blood)
	115.5	Carbapenem	Bacteroides fragilis	0.06 - 0.25	23.1	75%	58.2%
(10/17)
(w/ blood)
	7.7	Carbapenem	Staphylococcus
aureus	0.06 - 0.25	1.5	5%	100%
(17/17)
(w/ blood)

--- Page 7 ---
®
Table 1. Antimicrobial Neutralization BacT/ALERT FN Plus Culture Bottle
Initial
PSL
Antimicrobial MIC (µg/ml)1, testing % of % Recovery
Antimicrobial conc. Organism
Class 2, 3, 4, 5 conc. PSL (n/N)**
(µg/ml)*
(µg/ml)¥
Staphylococcus 70.6%
185 Carbapenem 0.06 -0.25 37.0 120%
aureus (12/17)
Staphylococcus 100%
Erythromycin Oral 2.4 Macrolide 0.25 -1 0.5 120%
aureus (17/17)
100%
Gentamicin 12 Aminoglycoside Escherichia coli 0.25 -1 2.4 120%
(17/17)
100%
48 Carbapenem Bacteroides fragilis 0.03 -0.125 9.6 120% (19/19)
(w/ blood)
Imipenem Enterococcus 100%
48 Carbapenem 0.5 -2 9.6 120%
faecalis (18/18)
Staphylococcus 100%
48 Carbapenem 0.015 -0.06 9.6 120%
aureus (17/17)
Enterococcus 100%
Levofloxacin 10.3 Fluoroquinolone 0.25 -2 2.1 120%
faecalis (17/17)
100%
Bacteroides fragilis 0.03 -0.25 9.8 100%
(22/22)
Meropenem 49 Carbapenem
52.9%
Staphylococcus
0.03 -0.12 9.8 100% (9/17)
aureus
(w/ blood)
100%
4.5 Fluoroquinolone Escherichia coli 0.008 -0.06 0.9 100%
(17/17)
Moxifloxacin
100%
5.4 Fluoroquinolone Bacteroides fragilis 0.125 -0.5 1.1 120%
(17/17)
Staphylococcus 100%
Ofloxacin 4.6 Fluoroquinolone 0.12 -1 0.92 100%
aureus (17/17)
100%
Peptoniphilus
N/A 3.6 120% (17/17)
asaccharolyticus
(w/ blood)
Oxacillin 18 b-lactam
Staphylococcus 100%
0.12 -0.5 3.6 120%
aureus (17/17)
5.9%
Clostridium
10 b-lactam 0.063 -0.27 2.0 50% (1/17)
perfringens
(w/ blood)
Penicillin G
100%
Streptococcus
24 b-lactam 0.25 -1 4.8 120% (17/17)
pneumoniae
(w/ blood)
b-lactam,
100%
188.2 / b-lactamase Staphylococcus
0.25/4 -2/4 37.6 / 3.8 100% (17/17)
20.8 inhibitor aureus
(w/ blood)
Piperacillin + combination
Tazobactam b-lactam,
100%
228 / b-lactamase
Bacteroides fragilis 0.125/4 -0.5/4 45.6 / 4.6 120% (17/17)
22.8 inhibitor
(w/ blood)
combination
Staphylococcus 100%
Telithromycin 2.3 Macrolide 0.06 -0.25 0.46 100%
aureus (17/17)
7

[Table 1 on page 7]
®
Table 1. Antimicrobial Neutralization BacT/ALERT FN Plus Culture Bottle							
Antimicrobial	PSL
conc.
(µg/ml)*	Antimicrobial
Class	Organism	MIC (µg/ml)1,
2, 3, 4, 5	Initial
testing
conc.
(µg/ml)¥	% of
PSL	% Recovery
(n/N)**
	185	Carbapenem	Staphylococcus
aureus	0.06 -0.25	37.0	120%	70.6%
(12/17)
Erythromycin Oral	2.4	Macrolide	Staphylococcus
aureus	0.25 -1	0.5	120%	100%
(17/17)
Gentamicin	12	Aminoglycoside	Escherichia coli	0.25 -1	2.4	120%	100%
(17/17)
Imipenem	48	Carbapenem	Bacteroides fragilis	0.03 -0.125	9.6	120%	100%
(19/19)
(w/ blood)
	48	Carbapenem	Enterococcus
faecalis	0.5 -2	9.6	120%	100%
(18/18)
	48	Carbapenem	Staphylococcus
aureus	0.015 -0.06	9.6	120%	100%
(17/17)
Levofloxacin	10.3	Fluoroquinolone	Enterococcus
faecalis	0.25 -2	2.1	120%	100%
(17/17)
Meropenem	49	Carbapenem	Bacteroides fragilis	0.03 -0.25	9.8	100%	100%
(22/22)
			Staphylococcus
aureus	0.03 -0.12	9.8	100%	52.9%
(9/17)
(w/ blood)
Moxifloxacin	4.5	Fluoroquinolone	Escherichia coli	0.008 -0.06	0.9	100%	100%
(17/17)
	5.4	Fluoroquinolone	Bacteroides fragilis	0.125 -0.5	1.1	120%	100%
(17/17)
Ofloxacin	4.6	Fluoroquinolone	Staphylococcus
aureus	0.12 -1	0.92	100%	100%
(17/17)
Oxacillin	18	b-lactam	Peptoniphilus
asaccharolyticus	N/A	3.6	120%	100%
(17/17)
(w/ blood)
			Staphylococcus
aureus	0.12 -0.5	3.6	120%	100%
(17/17)
Penicillin G	10	b-lactam	Clostridium
perfringens	0.063 -0.27	2.0	50%	5.9%
(1/17)
(w/ blood)
	24	b-lactam	Streptococcus
pneumoniae	0.25 -1	4.8	120%	100%
(17/17)
(w/ blood)
Piperacillin +
Tazobactam	188.2 /
20.8	b-lactam,
b-lactamase
inhibitor
combination	Staphylococcus
aureus	0.25/4 -2/4	37.6 / 3.8	100%	100%
(17/17)
(w/ blood)
	228 /
22.8	b-lactam,
b-lactamase
inhibitor
combination	Bacteroides fragilis	0.125/4 -0.5/4	45.6 / 4.6	120%	100%
(17/17)
(w/ blood)
Telithromycin	2.3	Macrolide	Staphylococcus
aureus	0.06 -0.25	0.46	100%	100%
(17/17)

--- Page 8 ---
®
Table 1. Antimicrobial Neutralization BacT/ALERT FN Plus Culture Bottle
Initial
PSL
Antimicrobial MIC (µg/ml)1, testing % of % Recovery
Antimicrobial conc. Organism
Class 2, 3, 4, 5 conc. PSL (n/N)**
(µg/ml)*
(µg/ml)¥
94.1%
Escherichia coli 0.03 - 0.25 0.13 100%
(16/17)
0.63 Glycylcycline
Streptococcus 100%
Tigecycline 0.015 - 0.12 0.13 100%
pneumoniae (17/17)
Staphylococcus 100%
0.76 Glycylcycline 0.03 - 0.25 0.15 120%
aureus (17/17)
100%
Tobramycin 12 Aminoglycoside Escherichia coli 0.25 - 1 2.4 120%
(17/17)
Trimethoprim / Sulfonamide Streptococcus 100%
11 / 126 0.12/2.4 - 1/19 2.2 / 25.2 120%
sulfamethoxazole combination pneumoniae (34/34)
100%
Clostridium
1 10.0 100% (17/17)
perfringens
(w/ blood)
Vancomycin 50 Glycopeptide
Staphylococcus 100%
0.5 - 2 10.0 120%
aureus (17/17)
1. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement.
CLSI document M100-S22. Wayne, Pa; Clinical and Laboratory Standards Institute; 2012.
2. Carman RJ and TD Wilkins. 1991. In vitro susceptibility of rabbit strains of Clostridium spiroforme to antimicrobial
agents. Veterinary Microbiology. 28:391-397
3. Stevens DL, K A Maier and J E Mitten. 1987. Effect of antibiotics on toxin production and viability of Clostridium
perfringens. Antimicrob. Agents Chemother.31: 213-218.
4. Zurenko G E, B H Yagi, R D Schaadt, J W Allison, J O Kilburn, S E Glickman, D K Hutchinson, M R Barbachyn
and S J Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
Antimicrob. Agents Chemother. 40: 839-845.
5. Goldstein, E.J.C, D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrell, and H. T. Fernandez. 2003. In vitro
activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307
Gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob. Agents Chemother. 47:337-341.
* Antimicrobial Therapy Inc. 2009 Sanford guide to antimicrobial therapy. Sperryville, VA.
** Growth of susceptible microorganism in the presence of antimicrobial
¥ Initial concentration achieved by the addition of 10mL of blood containing the %Peak Serum Level (PSL) of antibiotic
into 30mL of the BacT/ALERT® FN Plus culture medium.
Delayed Entry Study
A study was conducted to evaluate the effect of a delay, from the time the
BacT/ALERT® FN Plus Culture Bottle is inoculated, to the time the bottle is
8

[Table 1 on page 8]
®
Table 1. Antimicrobial Neutralization BacT/ALERT FN Plus Culture Bottle							
Antimicrobial	PSL
conc.
(µg/ml)*	Antimicrobial
Class	Organism	MIC (µg/ml)1,
2, 3, 4, 5	Initial
testing
conc.
(µg/ml)¥	% of
PSL	% Recovery
(n/N)**
							
Tigecycline	0.63	Glycylcycline	Escherichia coli	0.03 - 0.25	0.13	100%	94.1%
(16/17)
			Streptococcus
pneumoniae	0.015 - 0.12	0.13	100%	100%
(17/17)
	0.76	Glycylcycline	Staphylococcus
aureus	0.03 - 0.25	0.15	120%	100%
(17/17)
Tobramycin	12	Aminoglycoside	Escherichia coli	0.25 - 1	2.4	120%	100%
(17/17)
Trimethoprim /
sulfamethoxazole	11 / 126	Sulfonamide
combination	Streptococcus
pneumoniae	0.12/2.4 - 1/19	2.2 / 25.2	120%	100%
(34/34)
Vancomycin	50	Glycopeptide	Clostridium
perfringens	1	10.0	100%	100%
(17/17)
(w/ blood)
			Staphylococcus
aureus	0.5 - 2	10.0	120%	100%
(17/17)

--- Page 9 ---
placed on the instrument. The study was conducted at three study sites (one in-
house, and two external sites), each using a different lot of BacT/ALERT® FN
Plus Culture Bottles. Three replicates each of six isolates, namely, S. aureus, E.
coli, S. pneumoniae, E. faecium, B. fragilis and C. perfringenes, were tested using
an inoculum range from 41-253 CFU/bottle. In addition to the bacterial isolates,
each BacT/ALERT® FN Plus Culture Bottle was inoculated with 3-4 mLs of
blood from healthy volunteers. BacT/ALERT® FN Plus Culture Bottles were
tested at five different combinations of holding temperature/holding period, as
indicated below, prior to be loaded on to the instrument. The study results are
illustrated in Table 2 below.
· 2-8ºC for 48 hours
· 20-25ºC for 24 hours
· 20-25ºC for 36 hours
· 35-37ºC for 8 hours
· 35-37ºC for 24 hours
The study demonstrated that all holding conditions showed a percent recovery of
100% with the exception of those held at 35-37ºC for 24 hours, which
demonstrated a percent recovery of 80%. The decreased recovery of 80% was
due to 16 culture bottles seeded with isolates (4 isolates of E. faecium, and 12
isolates of S. pneumoniae) that were not flagged positive by the BacT/ALERT®
instrument. The BacT/ALERT® FN Plus Culture Bottle may not detect
microorganisms if held at 35-37ºC for 24 hours before loading and should
therefore be subcultured.
Table 2. Delayed Entry Study
Time to Detection from Sample Inoculation
Incubation
Sample Input Temperature Hold Time % Recovery (Hold Time + Instrument TTD in hours)
(hours)
(°C)
Mean Range
100.0%
Control No delay 15.9 9.5 - 52.8
(89/89)
2-8 48 100.0%
63.3 50.1 - 90.4
(65/65)
100.0%
20-25 24 34.7 26.0 - 79.2
Inoculated (62/62)
Test Bottles 100.0%
20-25 36 43.6 38.0 - 78.6
(62/62)
100.0%
35-37 8 17.7 10.0 - 53.4
(72/72)
80.0%¥
35-37 24 28.6 26.0 - 52.3
(64/80)
Negative 0.0%
All conditions - -
Controls (0/51)
¥CAUTION: Culture bottles held at 35 to 37°C for 24 hours or longer before loading may not detect microorganisms and should be
subcultured.
a. Precision/Reproducibility:
9

[Table 1 on page 9]
Sample Input	Incubation
Temperature
(°C)	Hold Time
(hours)	% Recovery	Time to Detection from Sample Inoculation
(Hold Time + Instrument TTD in hours)	
				Mean	Range
Inoculated
Test Bottles	Control	No delay	100.0%
(89/89)	15.9	9.5 - 52.8
	2-8	48	100.0%
(65/65)	63.3	50.1 - 90.4
	20-25	24	100.0%
(62/62)	34.7	26.0 - 79.2
	20-25	36	100.0%
(62/62)	43.6	38.0 - 78.6
	35-37	8	100.0%
(72/72)	17.7	10.0 - 53.4
	35-37	24	80.0%¥
(64/80)	28.6	26.0 - 52.3
Negative
Controls	All conditions		0.0%
(0/51)	-	-

--- Page 10 ---
Reproducibility
A reproducibility study was conducted to evaluate the BacT/ALERT® FN Plus
Culture Bottle. The study was conducted at three sites (one internal and two
external), for three days, with two operators, using three different instruments, and
three reagent lots. Eight microorganisms representative of those most commonly
associated with blood stream infection were seeded into the blood culture bottles at
inoculum levels ranging from 1 to 500 CFU/bottle, depending on the microorganism.
An initial total of 144 replicates were tested at each study site. Percent recovery
reflects those instances where the inoculated culture bottle was flagged positive by
the instrument and Gram stain/subculture were consistent with the seeded organism.
Table 3 provides a summary of the study results. The data in Table 3 includes repeat
testing performed due to a number of technical errors (i.e. contaminated culture
bottles/reagents, colony counts out of range and failure to change bottle status after
positive instrument signal and positive subculture). Data excluding the technical
errors demonstrated 100% recovery for all isolates with the exception of E. aerogenes
which exhibited 96.3% recovery for all sites combined.
Table 3. Reproducibility Study
% Recovery Time to Detection CFU/
Sample Input
Bottle
Site 1 Site 2 Site 3 Overall Mean Range
Staphylococcus aureus 96.3% 79.2% 100.0% 92.9% 20.2 18.5- 2-12
(26/27) (19/24) (33/33) (78/84) 35.7
Escherichia coli 100.0% 79.2% 100.0% 93.3% 12.8 11.4- 2-11
(18/18) (19/24) (33/33) (70/75) 20.8
Enterococcus faecalis 100.0% 83.3% 97.0% 94.3% 24.6 17.9- 2-15
(30/30) (20/24) (32/33) (82/87) 30.4
Clostridium perfringens 100.0% 96.8% 100.0% 98.2% 12.2 10.2- 3-122
(18/18) (61/63) (30/30) (109/111) 17.3
Enterobacter aerogenes 90.0% 75.0% 90.5% 86.5% 14.6 11.9- 1-270
(27/30) (18/24) (38/42) (83/96) 16.7
Listeria monocytogenes 100.0% 100.0% 100.0% 100.0% 22.8 20.6- 1-13
(21/21) (24/24) (33/33) (78/78) 37.0
Salmonella enterica 100.0% 79.2% 100.0% 93.6% 13.3 12.4- 1-16
(24/24) (19/24) (30/30) (73/78) 14.4
Streptococcus 100.0% 100.0% 100.0% 100.0% 17.5 13.3- 5-500
pneumoniae (30/30) (36/36) (18/18) (84/84) 23.1
Overall 98.0% 88.9% 98.0% 94.8%
(194/198) (216/243) (247/252) (657/693)
95% CI: 95% CI: 95% CI: 95% CI:
94.9%, 84.3%, 95.4%, 92.9%,
99.5% 92.6% 99.4% 96.3%
10

[Table 1 on page 10]
Sample Input	% Recovery				Time to Detection						CFU/
Bottle		
	Site 1	Site 2	Site 3	Overall	Mean			Range					
Staphylococcus aureus	96.3%
(26/27)	79.2%
(19/24)	100.0%
(33/33)	92.9%
(78/84)	20.2			18.5-
35.7			2-12		
Escherichia coli	100.0%
(18/18)	79.2%
(19/24)	100.0%
(33/33)	93.3%
(70/75)	12.8			11.4-
20.8			2-11		
Enterococcus faecalis	100.0%
(30/30)	83.3%
(20/24)	97.0%
(32/33)	94.3%
(82/87)	24.6			17.9-
30.4			2-15		
Clostridium perfringens	100.0%
(18/18)	96.8%
(61/63)	100.0%
(30/30)	98.2%
(109/111)	12.2			10.2-
17.3			3-122		
Enterobacter aerogenes	90.0%
(27/30)	75.0%
(18/24)	90.5%
(38/42)	86.5%
(83/96)	14.6			11.9-
16.7			1-270		
Listeria monocytogenes	100.0%
(21/21)	100.0%
(24/24)	100.0%
(33/33)	100.0%
(78/78)	22.8			20.6-
37.0			1-13		
Salmonella enterica	100.0%
(24/24)	79.2%
(19/24)	100.0%
(30/30)	93.6%
(73/78)	13.3			12.4-
14.4			1-16		
Streptococcus
pneumoniae	100.0%
(30/30)	100.0%
(36/36)	100.0%
(18/18)	100.0%
(84/84)	17.5			13.3-
23.1			5-500		
Overall	98.0%
(194/198)
95% CI:
94.9%,
99.5%	88.9%
(216/243)
95% CI:
84.3%,
92.6%	98.0%
(247/252)
95% CI:
95.4%,
99.4%	94.8%
(657/693)
95% CI:
92.9%,
96.3%									
													

--- Page 11 ---
Within-Laboratory Precision (Repeatability) Study
An in-house seeded study was conducted to evaluate the BacT/ALERT® FN Plus
Culture Bottle’s ability to repeatedly recover and detect microorganisms in the
presence of clinically relevant concentrations of antimicrobials to which the
microorganisms are susceptible, within five days after bottle inoculation. The study
was conducted over a period of 12 days, using multiple instruments, by a minimum of
two operators. A minimum of 108 replicates were tested for each
antimicrobial/organism combination. In the conduct of the study, the BacT/ALERT®
FN Plus culture bottles were subcultured at least 24 hours after being flagged positive
by the instrument. Table 4 illustrates the study results.
Table 4. Within-Laboratory Precision (Repeatability) Study
CFU/ Time to Detection
Sample Input % Recovery
bottle (hours)
Organism Antimicrobial (range) Lot 1 Lot 2 Lot 3 Overall Mean Range
B. fragilis Imipenem 136 - 406 100.0 100.0 100.0 100.0 36.9 30.2 –
55.2
C. perfringens Vancomycin 75 - 204 100.0 94.4 100.0 98.2 14.5 11.1 –
22.0
S. aureus Oxacillin 94 - 158 100.0 100.0 100.0 100.0 17.7 15.1 –
24.3
b. Linearity/assay reportable range:
Not applicable
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
Quality Control
Quality control (QC) was performed during the clinical trial using each of the
three organisms listed in Table 5 below. Isolates (one organism per bottle)
were tested according to a rotating schedule. Growth within 5 days after
inoculation was the expected result.
Serial dilutions of each isolate was prepared and seeded into the
BacT/ALERT® FN Plus Culture Bottle at a target inoculum of 100 CFU/bottle
with an acceptable range of 30-300 CFU/bottle. Overall QC results were
found to be acceptable. Instances where unacceptable QC results were
observed were found to be due to technical errors (i.e., colony counts out of
range, contaminated and mislabeled bottles). Repeat testing resulted in
acceptable results.
11

[Table 1 on page 11]
Sample Input		CFU/
bottle
(range)	% Recovery				Time to Detection
(hours)	
Organism	Antimicrobial		Lot 1	Lot 2	Lot 3	Overall	Mean	Range
B. fragilis	Imipenem	136 - 406	100.0	100.0	100.0	100.0	36.9	30.2 –
55.2
C. perfringens	Vancomycin	75 - 204	100.0	94.4	100.0	98.2	14.5	11.1 –
22.0
S. aureus	Oxacillin	94 - 158	100.0	100.0	100.0	100.0	17.7	15.1 –
24.3

--- Page 12 ---
Table 5. Quality Control Organisms (Anaerobic)
Bacteroides fragilis ATCC 25282
Bacteroides vulgatus ATCC 8482
Clostridium perfringens ATCC 13124
Stability (Shelf-life)
Studies were conducted to determine the stability (shelf-life) of the
BacT/ALERT® FN Plus Culture Bottle. Four lots of BacT/ALERT® FN Plus
culture bottles for design verification and three lots for product validation
were tested until they were 13 months old. At the beginning of the study,
bottles were thermally stressed, or not thermally stressed, and then stored at
either 15-30 ºC or 2-8 ºC for a total of four treatment/storage conditions. At
each time point, growth performance, antimicrobial neutralization and
physical parameters were evaluated. Bottles were also tested to determine if
they possessed sufficient vacuum to direct draw 10 mL of blood, and if
coagulation was prevented when direct blood draw was allowed to continue
until the bottle vacuum was exhausted.
Initial stability studies were conducted using a high target inoculum in
comparison to the limit of detection (LoD). Subsequent studies were
conducted using levels of organisms around the LoD using culture bottles at
end of shelf life, which demonstrated that stability can be achieved for the
claimed shelf life.
d. Detection limit:
The limit of detection (LoD) for the BacT/ALERT® FN Plus Culture Bottle
was determined using a panel of microorganisms listed in Table 6 below.
LoD is defined as the lowest inoculum level for which the detection
proportion is 95%. BacT/ALERT® FN Plus culture bottles were inoculated
with target microorganism concentration of 5 CFU/bottle and loaded into a
BacT/ALERT® 3D Microbial Detection System (BTA). All testing was done
in the absence of blood with the exception of 1 mL of blood for B. fragilis and
S. pneumoniae. A minimum of thirty replicates were tested for each organism.
At least 95% detection was achieved for all isolates tested at LoD. The LoD
values for the microorganisms tested are listed in Table 6 below.
12

[Table 1 on page 12]
	Table 5. Quality Control Organisms (Anaerobic)			
Bacteroides fragilis		ATCC 25282		
Bacteroides vulgatus		ATCC 8482		
Clostridium perfringens		ATCC 13124		

--- Page 13 ---
Table 6. Limit of Detection
Microorganism Strain Identification LoD (CFU/bottle)
Bacteroides fragilis ATCC 25285 5
Clostridium perfringens NCTC 8798 4
Enterobacter aerogenes ATCC 13048 8
Enterococcus faecalis NCTC 12697 4
Escherichia coli NCTC 12923 4
Listeria monocytogenes ATCC 15313 6
Salmonella enterica ATCC 14028 5
Staphylococcus aureus NCTC 10788 4
Streptococcus ATCC 6305 6
pneumoniae
Analytical Sensitivity (Growth Performance)
The data in Table 7 below represent results from in-house seeded studies with and
without blood obtained from healthy human volunteers. Multiple strains were
tested for each species at target inoculum levels of 125 CFU per bottle. Actual
inoculum levels ranged from 3 CFU/bottle to 299 CFU/bottle. In this seeded study
BacT/ALERT® FN Plus bottles were subcultured at least 24 hours after being
flagged positive by the instrument. The species listed are representatives of
clinically prevalent organisms in blood cultures and sterile body fluids.
13

[Table 1 on page 13]
	Table 6. Limit of Detection							
	Microorganism			Strain Identification			LoD (CFU/bottle)	
Bacteroides fragilis			ATCC 25285			5		
Clostridium perfringens			NCTC 8798			4		
Enterobacter aerogenes			ATCC 13048			8		
Enterococcus faecalis			NCTC 12697			4		
Escherichia coli			NCTC 12923			4		
Listeria monocytogenes			ATCC 15313			6		
Salmonella enterica			ATCC 14028			5		
Staphylococcus aureus			NCTC 10788			4		
Streptococcus
pneumoniae			ATCC 6305			6		

--- Page 14 ---
Table. 7. Growth Performance
Blood No Blood
Microorganism % Time to Detection (hours) % Time to Detection (hours)
Range Range
Recovery Recovery*
CFU/bottle CFU/bottle
(n) (n=3)
Mean Range Mean Range
100.0
Staphylococcus aureus 54 - 150 14.6 12.9 – 16.7 100 116 - 150 21.8 21.3 – 22.0
(15/15)
100.0
Escherichia coli 73 - 254 10.9 10.4 – 12.4 100 73 - 176 11.6 10.4 – 12.9
(15/15)
100.0
Bacteroides fragilis 9 - 154 29.7 24.3 - 43.6 66.7 (2/3) 19 - 154 97.2 79.2 - 115.2
(18/18)
100.0
Streptococcus pneumoniae 4 - 260 16.5 11.5 - 43.8 100 4 - 25 17.5 16.0 – 19.3
(15/15)
100.0
Clostridium perfringens 58 - 210 17.3 12.0 - 40.1 100.0 (8/8) 76 - 210 27.1 14.1 - 35.7
(18/18)
100.0
Klebsiella pneumoniae 89 - 123 11.2 10.4 - 13.1 100 95 - 123 12.6 12.1 - 13.4
(15/15)
70.6
Fusobacterium nucleatum 19 - 204 74.4 36.0 - 108.0 75.0 (3/4) 19 - 116 56.1 41.2 - 64.8
(12/17)
100.0
Streptococcus agalactiae 14 - 194 16.9 12.7 - 28.9 100 21 - 34 25.9 20.5 - 33.4
(15/15)
100.0
Enterococcus faecalis 63 - 259 13.7 11.9 - 19.4 100 71 - 169 22.4 17.8 - 24.8
(15/15)
80.0
Parvimonas micra 46 - 154 51.4 37.3 - 69.6 0.0 (0/4) 46 - 154 - -
(16/20)
100.0
Enterobacter cloacae 111 - 200 11.9 11.1 - 12.5 100 111 - 185 13 11.9 - 14.7
(15/15)
100.0
Proteus mirabilis 36 - 213 11.4 10.9 - 12.5 100 36 - 213 11.9 11.5 - 12.7
(15/15)
86.7
Eggerthella lenta 83 - 175 41 34.8 - 60.0 66.7 (2/3) 83 - 151 46 44.0 - 48.0
(13/15)
100.0
Staphylococcus epidermidis 44 - 135 21 17.4 - 25.3 100 44 - 105 29.3 24.5 - 36.8
(15/15)
100.0
Listeria monocytogenes 121 - 251 17.1 15.5 - 19.3 100 121 - 251 19.2 17.7 - 20.3
(15/15)
100.0
Clostridium tertium 24 12.5 11.4 – 13.5 100 24 14.8 14.1 – 16.0
(15/15)
50.0
Clostridium septicum 25 - 146 31.7 13.9 – 62.4 40.0 (2/5) 90 - 146 43.4 17.1 – 69.6
(20/40)
60.0
Peptoniphilus asaccharolyticus 49 - 296 50.9 34.4 – 79.2 25.0 (1/4) 81 - 296 44.7 -
(12/20)
Less than 100% detection was observed for some species, to include Capnocytophaga ochracea, Cardiobacterium
hominis, Haemophilus parainfluenzae, and Granulicatella adiacens.
*In case of less than 100% recovery, it is recommended to add blood such as sterile defibrinated horse blood (10% v/v).
14

[Table 1 on page 14]
Microorganism	Blood				No Blood			
	%
Recovery
(n)	Range
CFU/bottle	Time to Detection (hours)		%
Recovery*
(n=3)	Range
CFU/bottle	Time to Detection (hours)	
			Mean	Range			Mean	Range
Staphylococcus aureus	100.0
(15/15)	54 - 150	14.6	12.9 – 16.7	100	116 - 150	21.8	21.3 – 22.0
Escherichia coli	100.0
(15/15)	73 - 254	10.9	10.4 – 12.4	100	73 - 176	11.6	10.4 – 12.9
Bacteroides fragilis	100.0
(18/18)	9 - 154	29.7	24.3 - 43.6	66.7 (2/3)	19 - 154	97.2	79.2 - 115.2
Streptococcus pneumoniae	100.0
(15/15)	4 - 260	16.5	11.5 - 43.8	100	4 - 25	17.5	16.0 – 19.3
Clostridium perfringens	100.0
(18/18)	58 - 210	17.3	12.0 - 40.1	100.0 (8/8)	76 - 210	27.1	14.1 - 35.7
Klebsiella pneumoniae	100.0
(15/15)	89 - 123	11.2	10.4 - 13.1	100	95 - 123	12.6	12.1 - 13.4
Fusobacterium nucleatum	70.6
(12/17)	19 - 204	74.4	36.0 - 108.0	75.0 (3/4)	19 - 116	56.1	41.2 - 64.8
Streptococcus agalactiae	100.0
(15/15)	14 - 194	16.9	12.7 - 28.9	100	21 - 34	25.9	20.5 - 33.4
Enterococcus faecalis	100.0
(15/15)	63 - 259	13.7	11.9 - 19.4	100	71 - 169	22.4	17.8 - 24.8
Parvimonas micra	80.0
(16/20)	46 - 154	51.4	37.3 - 69.6	0.0 (0/4)	46 - 154	-	-
Enterobacter cloacae	100.0
(15/15)	111 - 200	11.9	11.1 - 12.5	100	111 - 185	13	11.9 - 14.7
Proteus mirabilis	100.0
(15/15)	36 - 213	11.4	10.9 - 12.5	100	36 - 213	11.9	11.5 - 12.7
Eggerthella lenta	86.7
(13/15)	83 - 175	41	34.8 - 60.0	66.7 (2/3)	83 - 151	46	44.0 - 48.0
Staphylococcus epidermidis	100.0
(15/15)	44 - 135	21	17.4 - 25.3	100	44 - 105	29.3	24.5 - 36.8
Listeria monocytogenes	100.0
(15/15)	121 - 251	17.1	15.5 - 19.3	100	121 - 251	19.2	17.7 - 20.3
Clostridium tertium	100.0
(15/15)	24	12.5	11.4 – 13.5	100	24	14.8	14.1 – 16.0
Clostridium septicum	50.0
(20/40)	25 - 146	31.7	13.9 – 62.4	40.0 (2/5)	90 - 146	43.4	17.1 – 69.6
Peptoniphilus asaccharolyticus	60.0
(12/20)	49 - 296	50.9	34.4 – 79.2	25.0 (1/4)	81 - 296	44.7	-

--- Page 15 ---
e. Analytical specificity:
In house seeded studies were conducted with cerebrospinal fluid, pleural fluid,
synovial fluid, plasma, blood, and blood clots. Aliquots of each of these
fluids also received white blood cells at concentrations relevant to bacteremia
in each given body fluid. Testing was conducted with and without
microorganisms. These substances neither interfered with recovery and
detection of organisms, nor did they generate false positive results in the
absence of organisms.
f. Assay cut-off:
Not Applicable
2. Comparison studies:
a. Method comparison with predicate device:
Clinical Study Results (Blood Cultures)
A multi-center clinical study was conducted at three different geographic sites in
the U.S. comparing performance of the BacT/ALERT® FN Plus (FN Plus) and
BacT/ALERT® FN (FN) blood culture bottles for anaerobic culture pairs that
received blood volumes between 6 ml and 10 ml (compliant pairs). A total of
2514 anaerobic bottle pairs were obtained from 1080 adult patients suspected of
blood stream bacterial/yeast infections. Subcultures of both bottles were
performed for any bottle in the set determined to be positive by the
BacT/ALERT® system. A pair of bottles was determined to have a positive status
if subculture of either the FN Plus or FN bottle was positive. A culture bottle was
determined to be a “True Positive” if the culture was flagged positive by the
BacT/ALERT® System and resulted in growth of the isolate upon subculture of
this bottle. True positive rates were calculated for the FN Plus and FN culture
bottles and the ratio of FN Plus true positives to FN true positives were calculated
to compare performance. Clinical isolates recovered were classified as significant,
contaminant, or unknown based on determination by the clinical trial sites.
A total of 312 isolates were recovered from all compliant anaerobic blood culture
pairs with a positive status. There were a total of 289 bottle pairs that recovered at
least 1 isolate by subculture of FN Plus or FN bottles. A total of 266 bottle pairs
recovered a single isolate and 23 bottle pairs recovered two isolates. The total
population reported in Table 8 comprises the 312 isolates recovered from positive
15

--- Page 16 ---
bottle pairs and 2225 negative bottle pairs for a total of 2537 results. The FN Plus
bottle detected a total of 282 isolates compared to the FN bottle that detected 192
isolates. Of the significant isolates, the FN Plus bottle detected a total of 202
isolates compared to the FN bottle that detected 150 significant isolates. Three
false positives were identified on subculture of positive FN Plus bottles and
comprised 0.12% (3/2537) of the study population.
The tables below compare results of the BacT/ALERT® FN Plus to BacT/ALERT®
FN blood cultures for all compliant blood culture bottles that yielded any number
of isolates on subculture (Table 8), a single isolate alone on subculture (Table 9),
and multiple isolates on subculture (Table 10). For greater detail relative to the
clinical study design and calculations of confidence intervals, refer to the
publication, Kondratovich, M.V. (2008) Comparing Two Medical Tests When
Results of Reference Standard Are Unavailable for Those Negative via Both Tests,
Journal of Biopharmaceutical Statistics, 18: 1; 145-166.
Table 8. All Compliant Pairs with Single and Multiple Isolates Combined (Blood Cultures)
Clinical FN Plus True % of FN Plus True FN True % of FN True Positives Ratio of True Positives
Determination Positives Positives in Population Positives in Population
Significant 8.0% (202/2537) 5.9% (150/2537) 1.347
202 150
Contaminant 2.3% (58/2537) 1.2% (30/2537) 1.933
58 30
Unknown 22 0.9% (22/2537) 12 0.5% (12/2537) 1.833
Total 282 11.1% (282/2537) 192 7.6% (192/2537) 1.469
One hundred sixty two (162) isolates were detected by both FN Plus and FN, 120 isolates were detected only by FN
Plus and 30 isolates were detected only by FN.
The ratio of true positive rates for overall isolates was 1.469 (282/192) with a 95% CI of (1.317, 1.621).
Table 9. All Compliant Pairs with Single Isolates (Blood Cultures)
Clinical FN Plus True FN True Ratio of True
Determination Positives Positives Positives*
Significant 1.331
177 133
Contaminant 1.889
51 27
Unknown 15 9 1.667
Total 243 169 1.438
*One hundred forty six (146) isolates were detected by both FN Plus and FN, 97 isolates were detected only by FN
Plus and 23 isolates were detected only by FN.
The ratio of true positive rates for overall single isolates was 1.438 (243/169) with a 95% CI of (1.286, 1.590).
16

[Table 1 on page 16]
Clinical
Determination	FN Plus True
Positives	% of FN Plus True
Positives in Population	FN True
Positives	% of FN True Positives
in Population	Ratio of True Positives
Significant		8.0% (202/2537)		5.9% (150/2537)	1.347
	202		150		
					
					
Contaminant		2.3% (58/2537)		1.2% (30/2537)	1.933
	58		30		
					
					
Unknown	22	0.9% (22/2537)	12	0.5% (12/2537)	1.833
Total	282	11.1% (282/2537)	192	7.6% (192/2537)	1.469

[Table 2 on page 16]
Clinical
Determination	FN Plus True
Positives	FN True
Positives	Ratio of True
Positives*
Significant			1.331
	177	133	
			
			
Contaminant			1.889
	51	27	
			
			
Unknown	15	9	1.667
Total	243	169	1.438

--- Page 17 ---
Table 10. All Compliant Pairs with Multiple Isolates (Blood Cultures)
Clinical FN Plus True FN True Ratio of True
Determination Positives Positives Positives*
Significant 1.471
25 17
Contaminant 2.333
7 3
Unknown 7 3 2.333
Total 39 23 1.696
*Sixteen (16) isolates were detected by both FN Plus and FN, 23 isolates were detected only by FN Plus and 7 isolates
were detected only by FN. The ratio of true positive rates for overall multiple isolates was 1.696 (39/23) with a 95% CI
of (1.088, 2.304).
In this clinical study, there were a total of 2218 compliant anaerobic blood culture
pairs of FN Plus and FN bottles with negative instrument results for both bottles
after 5 days of incubation. Among these pairs, terminal subcultures on both
bottles were performed for 63 pairs and 7 false negative results by both FN Plus
and FN bottles were observed; subculture of FN Plus bottles alone was performed
for 844 pairs and 4 false negative results were observed; both subcultures were
not performed for 1307 pairs of bottles. Results are summarized in Table 11
below.
Table 11. Summary of Percent False Positive from compliant Anaerobic blood culture pairs that were flagged
negative by instrument for both bottles
Subculture Subculture % False Negative % False Negative
Performed FN Plus Performed FN FN Plus FN
Yes Yes 11.1% (7/63)* 11.1% (7/63)
Yes No 0.5% (4/844) NA
*Of these 7 positive subcultures, 2 subcultures yielded isolates that are strict aerobes (Acinetobacter baumannii,
Pseudomonas aeruginosa). The FN Plus Bottle is not intended to detect strict aerobes from blood or other normally
sterile body fluids.
Overall false negative rate for FN Plus based on a subset of terminal subcultures was 1.2% (11/907) and excluding
strict aerobes was 1.0% (9/907)
A comparative yield of microorganisms (number of isolates) recovered on
subculture of FN Plus and FN cultures are presented in Table 12 below.
17

[Table 1 on page 17]
Clinical
Determination	FN Plus True
Positives	FN True
Positives	Ratio of True
Positives*
Significant			1.471
	25	17	
			
			
Contaminant			2.333
	7	3	
			
			
Unknown	7	3	2.333
Total	39	23	1.696

[Table 2 on page 17]
Subculture
Performed FN Plus	Subculture
Performed FN	% False Negative
FN Plus	% False Negative
FN
Yes	Yes	11.1% (7/63)*	11.1% (7/63)
Yes	No	0.5% (4/844)	NA

--- Page 18 ---
® ®
Table 12. Comparative Yield of Microorganisms from BacT/ALERT FN Plus and BacT/ALERT FN (number
of isolates) – Blood Cultures
BacT/ALERT® BacT/ALERT®
Group
FN Plus FN
Anaerobes* 10 4
Enterobacteriaceae 50 43
Enterococcus spp. 28 19
Yeasts 0 0
Other Gram-Negative 6 3
Other Gram-Positive 9 6
Coagulase-Negative Staphylococcus 93 53
Staphylococcus aureus 65 42
Streptococcus spp. 21 22
Note: Isolate table includes polymicrobic cultures.
*Anaerobic isolates recovered in clinical trial: Bacteroides caccae (4), Bacteroides fragilis (2), Lactobacillus spp. (1),
Peptostreptococcus micros (1), Peptostreptococcus spp (1), Prevotella denticola (1), Propionibacterium acnes (1),
Propionibacterium spp.
Clinical Study Results – (Sterile Body Fluid Cultures)
A multi-center clinical study was conducted at four different geographic sites in
the U.S. and Canada comparing the performance of the BacT/ALERT® FN Plus
(FN Plus) and BacT/ALERT® FN (FN) culture bottles with sterile body fluid
specimens (SBF). A total of 339 bottles pairs were obtained from 310 adult
patients suspected of SBF bacterial/yeast infections. Sterile body fluid types
evaluated were amniotic fluid, continuous ambulatory peritoneal dialysis (CAPD)
fluid, cerebrospinal fluid (CSF), peritoneal fluid, pleural fluid, and synovial fluid.
Clinical Isolates recovered were classified as significant, contaminant, or
unknown based on determination by the clinical trial sites.
A total of 77 isolates were recovered from all anaerobic SBF culture pairs with a
positive status. There were a total of 61 bottle pairs that recovered at least 1
isolate by subculture of FN Plus or FN bottles. A total of 50 bottle pairs recovered
a single isolate, 7 bottle pairs recovered two isolates, 3 bottle pairs recovered 3
isolates, and 1 bottle pair recovered 4 isolates. The total population reported in
Table 8 comprises the 77 isolates recovered from positive bottle pairs and 278
negative bottle pairs for a total of 355 results. The FN Plus bottle detected a total
of 72 isolates compared to the FN bottle that detected 59 isolates. Of the
significant isolates, the FN Plus bottle detected a total of 52 isolates compared to
the FN bottle that detected 50 isolates. No false positives were identified for the
FN Plus bottle from the study population (0/355).
Table 13 below compares results of the BacT/ALERT® FN Plus to BacT/ALERT®
FN SBF cultures that yielded single or multiple isolates on subculture. For
greater detail relative to the clinical study design and calculations of confidence
intervals, refer to the publication, Kondratovich, M.V. (2008) Comparing Two
18

[Table 1 on page 18]
Group	BacT/ALERT®
FN Plus	BacT/ALERT®
FN
Anaerobes*	10	4
Enterobacteriaceae	50	43
Enterococcus spp.	28	19
Yeasts	0	0
Other Gram-Negative	6	3
Other Gram-Positive	9	6
Coagulase-Negative Staphylococcus	93	53
Staphylococcus aureus	65	42
Streptococcus spp.	21	22

--- Page 19 ---
Medical Tests When Results of Reference Standard Are Unavailable for Those
Negative via Both Tests, Journal of Biopharmaceutical Statistics, 18: 1; 145-166.
Table 13. All Pairs with Single and Multiple Isolates Combined (Sterile Body Fluid Cultures)
Ratio of True
FN Plus % of FN True % of FN True Positives
Clinical FN True
True Positives in Positives in
Determination Positives
Positives Population Population
Significant 52 14.6% (52/355) 50 14.1% (50/355) 1.040
Contaminant 3.4% (12/355) 0.6% (2/355) 6.000
12 2
Unknown 8 2.2% (8/355) 7 2.0% (7/355) 1.143
Total 72 20.3% (72/355) 59 16.6% (59/355) 1.220
Fifty four (54) isolates were detected by both FN Plus and FN, 18 isolates were detected only by FN Plus and 5 isolates
were detected only by FN. The ratio of true positive rates for overall isolates was 1.220 (72/59) with a 95% CI of
(1.044, 1.396).
Table 14 below summarizes the minimum specimen volume achieved in
anaerobic SBF clinical trials.
Table 14. BTA FN Plus Sterile Body Fluids Fill Volume (ml) – Positive Status
Total No. Minimum Specimen
Specimen Type No. of Positives
Specimen Volume
CAPD 75 22 1.0
CSF 24 2 0.1
Peritoneal Fluid 106 16 0.3
Pleural Fluid 93 22 0.2
Synovial (joint) Fluid 41 10 0.2
Total 339 72
In this clinical study, there were 278 pairs of FN Plus and FN bottles with
negative instrument results for both bottles after 5 days of incubation. Among
these pairs, terminal subcultures on both bottles were performed for 166 pairs
and 11 false negative results by both FN Plus and FN bottles were observed.
Subculture on FN Plus bottles alone was performed for 112 pairs and 0 false
negative results were observed. Results are summarized in Table 15 below.
19

[Table 1 on page 19]
Clinical
Determination	FN Plus
True
Positives	% of FN True
Positives in
Population	FN True
Positives	% of FN True
Positives in
Population	Ratio of True
Positives
Significant	52	14.6% (52/355)	50	14.1% (50/355)	1.040
Contaminant		3.4% (12/355)		0.6% (2/355)	6.000
	12		2		
					
					
Unknown	8	2.2% (8/355)	7	2.0% (7/355)	1.143
Total	72	20.3% (72/355)	59	16.6% (59/355)	1.220

[Table 2 on page 19]
	Total No.
Specimen		Minimum Specimen
Specimen Type		No. of Positives	
			Volume
			
CAPD	75	22	1.0
CSF	24	2	0.1
Peritoneal Fluid	106	16	0.3
Pleural Fluid	93	22	0.2
Synovial (joint) Fluid	41	10	0.2
Total	339	72	

--- Page 20 ---
Table 15. Summary of Percent False Negatives from anaerobic SBF culture pairs that were flagged negative by
instrument for both bottles
% False
Subculture Subculture % False Negative
Negative
Performed FN Plus Performed FN FN Plus
FN
Yes Yes 6.6% (11/166)* 6.6% (11/166)*
Yes No 0.0% (0/112) N/A
* Of these 11 positive subcultures, 8 subcultures yielded isolates that were strict aerobes (2 Acinetobacter baumannii, 1
Candida albicans, 2 Candida parapsilosis, 1 Cryptococcus neoformans, 1 Micrococcus spp., 1 Pseudomonas
aeruginosa).
The FN Plus Bottle is not intended to detect strict aerobes from blood or other normally sterile body fluids.
Overall false negative rate for FN Plus based on a subset of terminal subcultures is 4.0% (11/278) and excluding strict
aerobes is 1.1% (3/278)
A comparative yield of microorganisms (number of isolates) recovered on
subculture of FN Plus and FN cultures are presented in Table 16 below.
Comparative Yield of Microorganisms from BacT/ALERT® FN Plus and BacT/ALERT® FN (number of
isolates) – Sterile Body Fluid Cultures
Table 16.
BacT/ALERT® BacT/ALERT®
Group
FN Plus FN
Anaerobes* 6 6
Enterobacteriaceae 9 8
Enterococcus spp. 14 11
Yeasts 4 2
Other Gram-Negative 2 1
Other Gram-Positive 1 0
Coagulase-Negative Staphylococcus 19 16
Staphylococcus aureus 9 9
Streptococcus spp. 8 6
Note: Isolate table includes polymicrobic cultures.
*Anaerobes recovered in clinical trial: Bacteroides fragilis (2: 1 FN Only; 1 FN Plus & FN),Clostridium ramosum (1
FN Plus & FN), Clostridium spp. (1 FN Plus & FN), Prevotella loescheii (1 FN Plus & FN), Prevotella
melaninogenica (1 FN Plus Only), Veillonella spp. (1 FN Plus & FN)
b. Matrix comparison:
Not Applicable
3. Clinical studies:
a. Clinical Sensitivity:
Not Applicable
20

[Table 1 on page 20]
Subculture
Performed FN Plus	Subculture
Performed FN	% False Negative
FN Plus	% False
Negative
FN
Yes	Yes	6.6% (11/166)*	6.6% (11/166)*
Yes	No	0.0% (0/112)	N/A

[Table 2 on page 20]
Group	BacT/ALERT®
FN Plus	BacT/ALERT®
FN
Anaerobes*	6	6
Enterobacteriaceae	9	8
Enterococcus spp.	14	11
Yeasts	4	2
Other Gram-Negative	2	1
Other Gram-Positive	1	0
Coagulase-Negative Staphylococcus	19	16
Staphylococcus aureus	9	9
Streptococcus spp.	8	6

--- Page 21 ---
b. Clinical specificity:
Not Applicable
c. Other clinical supportive data (when a. and b. are not applicable):
Not Applicable
4. Clinical cut-off:
Not Applicable
6. Expected values/Reference range:
Expected percent positives vary based on factors such as patient population, specimen
type, prevalence of significant organisms, site location, and contamination rates. The
expected values presented above are provided based on the clinical study conducted
to evaluate the FN Plus Culture Bottle:
Percent positive cultures were observed to be 11.1% (range: 8.7%-14.3%) overall and
8.0% (range: 6.4% - 9.3%) for significant isolates from three clinical trial sites in FN
Plus culture bottles that received 6 ml to 10 ml of blood.
Percent positive cultures were observed to be 20.3% (range: 17.0%-25.3%) overall
and 14.6% (range: 6.1% - 24.1%) for significant isolates from three clinical trial sites
in FN Plus culture bottles that received sterile body fluids.
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports
a substantial equivalence decision.
21